Page last updated: 2024-10-30

2-amino-3-phosphonopropionic acid and Brain Disorders

2-amino-3-phosphonopropionic acid has been researched along with Brain Disorders in 3 studies

2-amino-3-phosphonopropionic acid: metabotropic glutamate receptor antagonist; do not confuse AP-3 used as an abbreviation for this with enhancer-binding protein AP-3 (a trans-activator) or clathrin assembly protein AP-3
2-amino-3-phosphonopropanoic acid : A non-proteinogenc alpha-amino acid that is alanine in which one of the hydrogens of the terminal methyl group has been replaced by a dihydroxy(oxido)-lambda(5)-phosphanyl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marret, S1
Mukendi, R1
Gadisseux, JF1
Gressens, P1
Evrard, P1
Price, MT1
Romano, C1
Fix, AS1
Tizzano, JP1
Olney, JW1
McDonald, JW1
Johnston, MV1

Other Studies

3 other studies available for 2-amino-3-phosphonopropionic acid and Brain Disorders

ArticleYear
Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions.
    Journal of neuropathology and experimental neurology, 1995, Volume: 54, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; Alanine; Amino Acids; Animals; Brain; Brain Diseases; Embryonic and Fet

1995
Blockade of the second messenger functions of the glutamate metabotropic receptor is associated with degenerative changes in the retina and brain of immature rodents.
    Neuropharmacology, 1995, Volume: 34, Issue:8

    Topics: Alanine; Animals; Animals, Newborn; Asparagine; Brain Diseases; Excitatory Amino Acid Antagonists; I

1995
Neuroprotective synergism of 2-amino-3-phosphonoproprionate (D,L-AP3) and MK-801 against ibotenate induced brain injury.
    Neuroscience letters, 1992, Oct-12, Volume: 145, Issue:2

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Alanine; Animals; Brain; Brain Diseases; Dizocilpine Maleate;

1992